Upstart earnings: What to expect from the AI lender

  • 📰 MarketWatch
  • ⏱ Reading Time:
  • 38 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 19%
  • Publisher: 97%

Business News News

Business Business Latest News,Business Business Headlines

Upstart Holdings Inc.’s controversial stock will be put to the test Tuesday afternoon when the company posts earnings. Shares of Upstart UPST have nearly quadrupled so far this year, although they’re off 87% from their all-time closing high of $390, achieved in October 2021.

Upstart Holdings Inc.’s controversial stock will be put to the test Tuesday afternoon when the company posts earnings.

Shares of Upstart UPST have nearly quadrupled so far this year, although they’re off 87% from their all-time closing high of $390, achieved in October 2021. Shares of the lending company have been riding the wave of enthusiasm for artificial intelligence, while Upstart has also shown improvements to a business that has struggled in a higher-rate and more uncertain macroeconomic environment.

Stock movement: Upstart shares tend to make wild swings after earnings. The company has posted results 10 times since going public, and nine of those reports were followed by a double-digit-percentage swing in the next trading session. Upstart shares have gained following each of the company’s past two reports, and they’re up 284% so far this year.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 3. in BUSİNESS

Business Business Latest News, Business Business Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Ginkgo Bioworks stock pops as company plans Merck collaborationGinkgo Bioworks Holdings Inc. shares were rising more than 5% in Monday’s premarket trading after the company said it was collaborating with Merck & Co. Inc....
Source: MarketWatch - 🏆 3. / 97 Read more »